Mycobacterium tuberculosis-associated synthetic mycolates differentially exert immune stimulatory adjuvant activity
Loading...
Date
Authors
Smet, Muriel
Pollard, Charlotte
De Beuckelaer, Ans
Van Hoecke, Lien
Vander Beken, Seppe
De Koker, Stefaan
Al Dulayymi, Juma’a R.
Huygen, Kris
Baird, Mark S.
Journal Title
Journal ISSN
Volume Title
Publisher
Wiley
Abstract
Mycolic acids (MAs) are highly hydrophobic long-chain α-alkyl β-hydroxy fatty acids present in the cell wall of Mycobacterium tuberculosis (Mtb) as a complex mixture of molecules with a common general structure but with variable
functional groups in the meromycolate chain. In this study, we addressed the relationship between the MA molecular structure and their contribution to the development of T-cell immune responses. Hereto, we used the model antigen
ovalbumin and single synthetic MAs, differing in oxygenation class and cis versus trans proximal cyclopropane configuration, as immune stimulatory agents. Subcutaneous delivery of liposome-formulated MAs with a proximal cis
cyclopropane elicited antigen-specific Th1 and cytotoxic T-cell immune responses, whereas intratracheal immunization elicited pulmonary Th17 responses. These immune stimulatory activities depended not only on the cis
versus trans proximal cyclopropane configuration but also on the MA oxygenation class. Our study thus shows that both the presence and nature of the functional groups in the meromycolate chain affect the immune stimulatory
adjuvant activity of Mtb mycolates and suggests that Mtb bacilli may impact on the host protective immune response by modulating the cis versus trans stereochemistry of its mycolates as well as by altering the oxygenation class of the meromycolate functional group.
Description
Keywords
Adjuvant biolipids, Mycolic acid, T-cell responses, Mycobacterium tuberculosis (MTB)
Sustainable Development Goals
Citation
Smet, M., Pollard, C., De Beuckelaer, A. et al. 2016, 'Mycobacterium tuberculosis-associated synthetic mycolates differentially exert immune stimulatory adjuvant activity', European Journal of Immunology, vol. 46, no. 9, pp. 2149-2154.
